DermTech, Inc. Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
DMTK Company Description
DermTech Inc is an emerging growth molecular diagnostic company. The company is engaged in marketing and developing novel non-invasive genomic tests to aid in the diagnosis of various skin conditions, including skin cancer, inflammatory diseases, and aging-related conditions. While the company generates revenue through laboratory services.
DMTK Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view DMTK Smart Score
Score Breakdown
DMTK Company Description
Show More
DermTech Inc is an emerging growth molecular diagnostic company. The company is engaged in marketing and developing novel non-invasive genomic tests to aid in the diagnosis of various skin conditions, including skin cancer, inflammatory diseases, and aging-related conditions. While the company generates revenue through laboratory services. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of DMTK by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by DMTK's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of DMTK in WallStreetBets Daily Discussion
DMTK News
Recent insights relating to DMTK
CNBC Recommendations
Recent picks made for DMTK stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in DMTK
Corporate Flights
Flights by private jets registered to DMTK
Our Analysis